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Background. Depression is a common disorder among older adults, and it has been associated with adverse outcomes,
including increased risk of morbidity and mortality as well as incomplete or delayed recovery from illness and disability.
The objective of this study was to examine whether depressive symptoms and anemia are associated among older adults
living in the community.
Methods. We used data from the ‘‘Invecchiare in Chianti’’ (Aging in the Chianti area, InCHIANTI) study, a prospective
population-based study of older people living in the community. Anemia was defined by the World Health Organization
(WHO) criteria: hemoglobin concentration below 12 g/dl in women and below 13 g/dl in men. Depressive symptoms were
measured by using the Center for Epidemiological Studies Depression Scale (CES-D). Participants with a CES-D score
16 were considered to be depressed.
Results. Mean age of the 986 participants was 75 years, and 56% were female; 313 (32%) study participants were
depressed. Anemia was recorded in 48 of the 313 (15%) participants with depression and in 53 of the 673 (8%)
participants without depression ( p , .001). After adjusting for potential confounders, depression was associated with
a significant higher risk of anemia (odds ratio ¼ 1.93; 95% confidence interval, 1.19–3.13). The risk of anemia pro-
gressively and significantly increased with increasing CES-D score (signifying more severe depression). Compared with
nondepressed participants (CES-D score ,16), the odds ratio for anemia were 1.74, 2.04, and 2.10 for participants with
mild (score¼16–20), moderate (score¼21–26), and severe depression (score. 26), respectively ( p for linear trend¼ .01).
Conclusions. Depressive symptoms are associated with anemia in a general population of older persons living in
the community.
DEPRESSION in the older population is a major healthissue, both because of its high prevalence and because
of its adverse heath consequences. About 12%–20% of
community-dwelling older person suffer from symptoms of
depression (1,2). Many cross-sectional studies have dem-
onstrated that, compared with nondepressed persons, de-
pressed older persons have poorer health status, higher
prevalence of disability, and more severe comorbidity (3,4).
In addition, longitudinal studies have shown that depression
represents a risk factor for adverse outcomes including
increased morbidity, mortality, and incomplete or delayed
recovery from illness and disability (5–8).
Anemia is rather common in old age with a prevalence
of about 13% in persons aged 70 years or older (9). This
condition is assumed to be due to underlying disease such as
cancer, renal failure, and infectious disease, and it has been
associated with a number of other comorbidities, such as
cardiovascular disease (10). This high burden of comorbidity
may negatively affect quality of life and lead to the onset of
depressive symptoms (11). Moreover, in studies conducted in
hemodialysis patients (12,13), it has been shown that anemia
directly affects brain function, and it is responsible for the
cognitive impairments and symptoms frequently suffered by
persons with chronic renal failure (confusion, inability to
concentrate, decreased mental alertness, and impaired mem-
ory). Reduced muscle strength and fatigue are commonly
associated with anemia and may have detrimental effects on
participants’ quality of life, therefore facilitating the de-
velopment of depressive symptoms (14,15). Finally, malnu-
trition, a common feature in depressed individuals, may be
responsible for anemia (10,16). Despite numerous hypothetical
pathways suggesting a link between anemia and depression,
the association between these two common conditions has
rarely been explored in a general population of older adults
(17). Therefore, the aim of the present study is to examine
whether depressive symptoms are associated with anemia,
independent of comorbidity and other potential confounders.
METHODS
We used data from the ‘‘Invecchiare in Chianti’’ (Aging
in the Chianti area, InCHIANTI) study, a population-based
study of older people conducted by the Italian National
Research Council of Aging (INRCA, Florence, Italy). The
InCHIANTI study includes 1156 participants aged 65 years
and older who were randomly selected from the residents in
two towns of the Chianti geographic area (Greve In Chianti
and Bagno a Ripoli, Tuscany, Italy) (18).
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Anemia
Details on blood sampling and determination of biological
parameters are reported elsewhere (14,15,18). Anemia was
defined by the World Health Organization (WHO) criteria
(19): Hemoglobin concentration below 12 g/dl in women
and below 13 g/dl in men. A ratio between serum transferrin
receptor and log(ferritin) above 1.5 was used to define iron
deficiency (20). A cutoff of 350 pg/ml (258 pmol/L) was
used to identify vitamin B12 deficiency (21).
Depression
Depressive symptoms were measured by using the 20-
item Center for Epidemiological Studies Depression Scale
(CES-D) (22). Participants with a CES-D score 16 were
considered to be depressed (23,24). In addition, to explore
a potential trend between depressive symptom severity and
anemia, we defined four participant groups by CES-D score,
based on cutoffs previously reported (25): (1) few or no
symptoms of depression (CES-D score , 16) (n ¼ 673),
(2) mild depressive symptoms (score ¼ 16–20) (n ¼ 126),
(3) moderate depressive symptoms (score ¼ 21–26) (n ¼
96), and (4) severe depression (score . 26) (n¼ 91).
Covariates
A Mini-Mental State Examination (MMSE) score below
18 was used to define cognitive impairment (26,27). The
presence of comorbid conditions was determined using an
adjudication process that included self-reported history,
medical examination data, and medical records information
(18). Kidney disease was determined by a serum creatinine
level above 1.5 mg/dl in women and above 1.7 mg/dl in
men. Based on tertiles of interleukin-6, participants were
classified in three groups. Assessment of daily caloric and
protein intake was performed based on the questionnaire of
the European Prospective Investigation into Cancer and Nu-
trition (28). Drugs were coded according to the Anatom-
ical Therapeutic and Chemical codes (29).
Study Sample and Statistical Analyses
From the initial sample of 1156 participants, we excluded
persons with missing data on hemoglobin level (n ¼ 119,
10.3%) or CES-D score (n ¼ 76, 6.6%). This selection re-
sulted in a final sample size of 986 participants. In compari-
son to those who were excluded from study participation
due to incomplete data (n¼170), those included in the study
were significantly younger (756 7 vs 826 9 years, p, .001)
and tended to be less often female (56% vs 62%, p¼ .18).
Differences between depressed and nondepressed partic-
ipants in categorical parameters were tested using the chi-
square test. Differences between continuous variables were
assessed by analysis of variance comparisons for normally
distributed parameters; alternatively, the Kruskal–Wallis test
was adopted. To establish whether depression represented
a risk factor for anemia, a logistic regression model was
performed in the 986 participants included in this study.
To explore a potential trend between depressive symptom
severity and anemia, an additional logistic regression model
was conducted, using categorization of the CES-D scores as
described above. Variables considered for adjustment were
those associated with depression at p  .10 in the univariate
analyses. All analyses were performed using SPSS for
Windows version 10.0 (Chicago, IL).
RESULTS
Participant Characteristics
Mean (6 standard deviation) age of the 986 participants
entering this study was 75 (67) years, and 56% of the study
population was female. The mean (6 standard deviation)
CES-D score in the total sample was 12.8 (68.7) (range 0–
48), and 313 (32%) of the study participants were depressed
(CES-D score  16). Other characteristics of the study
population are summarized in Table 1. Compared with
nondepressed participants, those with depression were older,
more likely to be female and enrolled in the Bagno a Ripoli
site, less likely to be smokers and drinkers, had a lower
education, had a higher prevalence of cognitive impairment,
and presented a higher number of diseases. In particular,
depression was associated with a higher prevalence of
coronary artery disease, peripheral artery disease, conges-
tive heart failure, and history of cancer. Finally, participants
with depression were more likely using antidepressant medi-
cation, nonsteroidal anti-inflammatory dugs, and acetyl-
salicylic acid.
Depression and Anemia
Anemia was identified in 101 (10%) study participants:
43 (10%) men and 58 (10%) women. As shown in Table 2,
anemia was present in 48/313 (15%) participants with
depression and in 53/673 (8%) participants without de-
pression ( p , .001). After adjusting for potential con-
founders, depression was associated with a significantly
increased risk of anemia (odds ratio [OR] ¼ 1.93; 95%
confidence interval [CI], 1.19–3.13). In the fully adjusted
model, no significant interaction was observed between
depression and sex ( p ¼ .30) and between depression and
age ( p¼ .35) on the risk of anemia.
The association between depression and anemia was
persistent using a CES-D cutoff of 21 to define depression.
Compared with participants scoring, 21, those with a score
of 21 or higher were more likely to present with anemia
(anemia among depressed participants: 30/187 [16%] vs
anemia among nondepressed participants: 71/799 [9%]; p¼
.004), and this association was confirmed after adjusting for
potential confounders (OR ¼ 1.78; 95% CI, 1.06–3.00).
As shown in Table 2, depression was still significantly
associated with anemia after exclusion of anemia related to
iron (transferrin receptor/log[ferritin] , 1.5) (OR ¼ 2.11;
95% CI, 1.23–3.60) or vitamin B12 deficiency (OR¼ 1.96;
95% CI, 1.01–3.80). To explore whether poor health status
or cognitive impairment could explain the association
between depression and anemia, we repeated analyses after
excluding participants with relevant comorbidities (such as
congestive heart failure, kidney disease, history of cancer,
or cognitive impairment). These analysis also yielded sig-
nificant associations of depression with anemia.
Figure 1 summarizes the ORs for anemia across different
groups, according to CES-D scores. After adjusting for
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potential confounders, the risk of anemia progressively and
significantly increased as CES-D score increments increased
(signifying more severe depression) ( p for linear trend¼ .01).
Compared with nondepressed participants whose CES-D
score was,16, the ORs for anemia were 1.74, 2.04, and 2.10
for participants with mild (score¼16–20), moderate (score¼
21–26), and severe depression (score . 26), respectively.
DISCUSSION
Based on our findings among persons living in the
community, depression appears to be associated with
anemia, irrespective of comorbidity and other potential
confounders. This association increases with severity of
depressive symptoms.
How could we explain a link between depression and
anemia? It has been hypothesized that psychological distress
can activate neuroregulated biological processes. This
activation can result in a diminished ability to combat
pathological processes, thus favoring the onset of negative
outcomes such as anemia. This phenomenon, described by
Engel (30) as the ‘‘giving-up–given-up complex,’’ could
explain the increased risk of adverse outcomes observed
among depressed participants. According to this hypothesis,
depression adversely affects cardiac, gastrointestinal, endo-
crine, neurologic, and immune processes by increasing
sympathetic tone and decreasing vagal tone (31). More
specifically, the higher risk of anemia that we observed
among depressed participants may be due to a number of
factors. First, psychological distress has been associated
with an increased risk of occult bleeding, which can be
responsible for a higher prevalence of anemia among
depressed persons (32). Second, the increased sympathetic
Table 1. Baseline Characteristics According to Depression Status
Characteristic
No Depression
N ¼ 673 (%)
Depression
N ¼ 313 (%) p*
Age ,.001
,80 y 559 (83) 211 (67)
80 y 114 (17) 102 (33)
Female sex 322 (48) 232 (74) ,.001
Site .06
Bagno a Ripoli 342 (51) 179 (56)
Greve in Chianti 331 (49) 134 (43)
Education .06
0–5 y 480 (71) 244 (78)
6–8 y 122 (18) 36 (12)
9–13 y 47 (7) 20 (6)
.13 y 23 (3) 13 (4)
Body mass index .23
,25 kg/m2 171 (25) 95 (30)
25–29.9 kg/m2 340 (51) 173 (46)
30 kg/m2 162 (24) 75 (24)
Smoking ,.001
Never 349 (52) 227 (73)
Former 241 (36) 56 (18)
Current 83 (12) 30 (10)
Alcohol use 443 (66) 171 (55) .001
Cognitive impairmenty 15 (2) 14 (5) .05
No. of diseases, mean 6 SD 2.6 6 1.1 2.7 6 1.2 .09
Diabetes 71 (10) 31 (10) .76
Coronary artery disease 56 (8) 37 (12) .08
Peripheral artery disease 48 (7) 32 (10) .09
Congestive heart failure 24 (4) 22 (7) .02
Stroke 38 (6) 23 (7) .30
Pulmonary disease 45 (7) 20 (6) .86
History of cancer 36 (5) 26 (8) .08
Gastric disease 33 (5) 16 (5) .89
Peptic ulcer 104 (16) 45 (14) .66
Renal failurez 6 (1) 5 (2) .33
Albumin (g/dL), mean 6 SD 4.2 6 0.3 4.2 6 0.3 .13
Energy intake (kcal/kg per day) 28.8 6 8.4 28.0 6 8.1 .15
Protein intake (g/kg per day) 1.1 6 0.3 1.1 6 0.3 .32
IL-6 (pg/mL) tertiles .65
,1.03 217 (32) 110 (35)
1.03–1.84 227 (34) 100 (32)
1.85 228 (34) 101 (33)
Use of antidepressants 13 (2) 24 (8) ,.001
Use of NSAIDs 122 (18) 90 (29) ,.001
Use of ASA 92 (14) 56 (18) .08
Notes: Depression was defined as Center for Epidemiological Studies
Depression Scale (CES-D) score  16.
*p values are based on chi-square test for categorical variables, analysis of
variance for continuous variables.
yCognitive impairment was defined by Mini-Mental State Examination
score , 18.
zRenal failure was determined by a serum creatinine level above 1.5 mg/dL
in women and above 1.7 mg/dL in men.
SD ¼ standard deviation; NSAIDs ¼ nonsteroidal anti-inflammatory drugs;
ASA ¼ acetylsalicylic acid.
Table 2. Association Between Depression and Anemia
Patients With N Anemia p
OR (95% CI)
for Anemia*
Total sample
No depression 673 53 (8%) ,.001 1
Depression 313 48 (15%) 1.93 (1.19–3.13)
Sample without congestive heart failure, kidney disease,
and history of cancer
No depression 586 45 (8%) .001 1
Depression 255 39 (15%) 2.06 (1.21–3.49)
Sample without cognitive impairmenty
No depression 658 49 (7%) .001 1
Depression 299 43 (14%) 1.93 (1.17–3.19)
Sample without iron deficiency anemiaz
No depression 657 37 (6%) ,.001 1
Depression 305 40 (13%) 2.11 (1.23–3.60)
Sample without vitamin B12 deficiency anemia{
No depression 644 24 (4%) .003 1
Depression 289 24 (8%) 1.96 (1.01–3.80)
Notes: *Adjusted for age, sex, site, education, smoking, alcohol use,
cognitive impairment, number of diseases, coronary artery disease, peripheral
artery disease, congestive heart failure, history of cancer, use of antidepressants,
use of nonsteroidal anti-inflammatory drugs, and use of acetylsalicylic acid.
yCognitive impairment was defined by Mini-Mental State Examination
score , 18.
zIron deficiency was defined by (serum transferrin receptor/log[ferritin],1.5).
{Vitamin B12 deficiency was defined by vitamin B12 , 350 pg/ml (258
pmol/L).
OR ¼ odds ratio; CI ¼ confidence interval; CES-D ¼ Center for Epi-
demiological Studies Depression Scale. Depression was defined as CES-D  16;
anemia was defined as Hb , 12 g/dL for women and , 13 g/dL for men.
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tone, observed among depressed persons (31), can regulate
bone marrow microenvironment, affecting erythropoiesis
(33). Third, anemia can represent a consequence of
malnutrition among depressed persons (16). However, the
fact that daily caloric and protein intake did not differ
significantly according to depressive status makes this
explanation unlikely.
Another possible explanation for our findings is that
depressive symptoms may occur as a consequence of
anemia. Anemia may directly affect brain function. Some
studies conducted in hemodialysis patients (12,13) have
shown that anemia appears to contribute to impaired cog-
nitive function and that persons with chronic renal failure
frequently suffer from confusion, inability to concentrate,
decreased mental alertness, and impaired memory. In addi-
tion, acute isovolemic anemia results in subtle slowing of
data-processing ability in humans and degrades memory
(12). Previous studies conducted among hemodialysis
patients (13,34) have shown that correction of renal anemia
with erythropoietin improves quality of life, cognition, and
depressive symptoms. This improvement of psychological
symptoms seems to be mediated by an increment of oxy-
gen delivery to the brain and particularly to frontotemporal
and subcortical brain structures, which are involved in
the depression pathway (35,36). Finally, fatigue, which is
a common symptom of anemia, can have detrimental effects
on a person’s quality of life and determine the onset of
depressive symptoms (15,16).
An alternative explanation to our findings is that the link
between anemia and depression is caused by underlying
disease. Although restricted analyses among healthier par-
ticipants did not change our results, we can not rule out
that (unmeasured) diseases affected our results.
The prevalence of depression in our study is higher
compared with other observations. A possible explanation
for this finding is the low socioeconomic status of this
population (as suggested by the low educational status of
participants in this study), a factor that has been directly
associated with depression (37). However, the prevalence of
depression in this study did not differ substantially from that
observed in a general population in Northern Italy (38).
Depressive symptoms have been associated with vitamin
B12 deficiency, a factor potentially related to anemia (39).
Therefore, we repeated the analysis after excluding cases of
anemia related to vitamin B12 deficiency, and achieved
results similar to those from the whole sample.
The present study has several limitations. We did not
explicitly determine the underlying cause of anemia.
Therefore, we may have missed the presence of some other
diseases or factors such as liver or pancreatic disease,
inflammatory bowel disease, and pernicious anemia, which
could have explained some of the findings. In addition,
although we adjusted all analyses for several potential
confounders, including common chronic conditions, it is
possible that anemia is simply an indicator of poor health
status, and that its association with depression is illustrative
of that. Finally, because of the cross-sectional design of the
study, we were not able to identify a causal relationship
between anemia and depression.
Conclusion
Our findings indicate that depression, possibly indepen-
dent of its underlying cause, is associated with anemia in
a general population of older persons living in the
community. Future longitudinal studies should confirm
and explain the reason for this association.
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